Literature DB >> 11827795

Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.

Karen M Yeow1, Narendra S Kishnani, Mike Hutton, Susan P Hawkes, Gillian Murphy, Dylan R Edwards.   

Abstract

The TIMP family of matrix metalloproteinase inhibitors consists of four members, of which TIMP-1, -2 and -4 are secreted, freely diffusible proteins, whereas TIMP-3 is ECM-associated. Mutations in the TIMP3 gene have been linked to Sorsby's fundus dystrophy (SFD), an autosomal dominant inherited retinal degenerative disease that leads to blindness. The SFD mutations characterized result in introduction of an unpaired cysteine residue in the C-terminal domain of TIMP-3. We have expressed four SFD mutant TIMP-3 proteins in baby hamster kidney (BHK) cells and evaluated their characteristics alongside wild-type TIMP-3. Analysis of the mutant proteins (Ser156Cys, Gly167Cys, Tyr168Cys and Ser181Cys) by SDS-PAGE and reverse zymography revealed that each of the mutants retained gelatinase A and gelatinase B inhibitory activity, and were localized to the ECM. Association rate constants for Ser156Cys TIMP-3 with gelatinase-A, gelatinase-B, stromelysin-1 and collagenase-3 were only moderately reduced compared to wild-type TIMP-3. However, all of the mutants displayed aberrant protein-protein interactions, resulting in the presence of additional proteins or complexes in ECM preparations. Two of the mutants (Ser156Cys and Ser181Cys) showed a marked propensity to form multiple higher molecular-weight complexes that retained TIMP activity on reverse zymography. Expression of the SFD mutant TIMP-3 (and to a lesser extent, wild-type TIMP-3) proteins in BHK cells conferred increased cell adhesiveness to the ECM. Our findings indicate that the pathogenesis of Sorsby's fundus dystrophy cannot be attributed to a failure to localize SFD TIMP-3 proteins to the ECM or defects in MMP inhibition, but may involve the formation of aberrant TIMP-3-containing protein complexes and altered cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11827795     DOI: 10.1016/s0945-053x(01)00180-9

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  11 in total

1.  A novel TIMP3 mutation associated with a retinitis pigmentosa-like phenotype.

Authors:  Meghan J DeBenedictis; Yosef Gindzin; Enrico Glaab; Bela Anand-Apte
Journal:  Ophthalmic Genet       Date:  2020-07-27       Impact factor: 1.803

Review 2.  The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.

Authors:  Keith Brew; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2010-01-15

3.  Effects of interferon-alpha on expression of hepatic stellate cell and transforming growth factor-beta1 and alpha-smooth muscle actin in rats with hepatic fibrosis.

Authors:  Xin-Ming Chang; Ying Chang; Ai Jia
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

Review 4.  Sorsby fundus dystrophy: Insights from the past and looking to the future.

Authors:  Bela Anand-Apte; Jennifer R Chao; Ruchira Singh; Heidi Stöhr
Journal:  J Neurosci Res       Date:  2018-08-21       Impact factor: 4.164

5.  Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix components.

Authors:  Sarah Vierkotten; Philipp S Muether; Sascha Fauser
Journal:  PLoS One       Date:  2011-08-02       Impact factor: 3.240

Review 6.  Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD).

Authors:  Luis García-Onrubia; Fco Javier Valentín-Bravo; Rosa M Coco-Martin; Rogelio González-Sarmiento; J Carlos Pastor; Ricardo Usategui-Martín; Salvador Pastor-Idoate
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

Review 7.  Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics.

Authors:  Hideaki Nagase; Keith Brew
Journal:  Arthritis Res       Date:  2002-05-09

8.  Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy.

Authors:  Z Saihan; Z Li; J Rice; N A Rana; S Ramsden; P G Schlottmann; S A Jenkins; C Blyth; G C Black; N McKie; A R Webster
Journal:  Mol Vis       Date:  2009-06-15       Impact factor: 2.367

Review 9.  Age-related macular degeneration and changes in the extracellular matrix.

Authors:  Małgorzata Nita; Barbara Strzałka-Mrozik; Andrzej Grzybowski; Urszula Mazurek; Wanda Romaniuk
Journal:  Med Sci Monit       Date:  2014-06-18

10.  The N-terminal p.(Ser38Cys) TIMP3 mutation underlying Sorsby fundus dystrophy is a founder mutation disrupting an intramolecular disulfide bond.

Authors:  Sarah Naessens; Julie De Zaeytijd; Delfien Syx; Roosmarijn E Vandenbroucke; Frédéric Smeets; Caroline Van Cauwenbergh; Bart P Leroy; Frank Peelman; Frauke Coppieters
Journal:  Hum Mutat       Date:  2019-02-06       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.